Primary female genital system lymphoma: a single institution's experience over 10 years
Wen-Xiao Wei
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorJia-Jia Huang
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorYu Wang
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorYi Xia
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorXi-Wen Bi
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorWen-Qi Jiang
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorHui-Qiang Huang
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorTong-Yu Lin
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorCorresponding Author
Zhi-Ming Li
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
E-mail: [email protected]
Search for more papers by this authorWen-Xiao Wei
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorJia-Jia Huang
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorYu Wang
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorYi Xia
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorXi-Wen Bi
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorWen-Qi Jiang
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorHui-Qiang Huang
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorTong-Yu Lin
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
Search for more papers by this authorCorresponding Author
Zhi-Ming Li
Sun Yat-sen University Cancer Center, Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060 China
E-mail: [email protected]
Search for more papers by this authorThese authors contributed equally to this manuscript.
References
- 1
Harris NL,
Scully RE. Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. A clinicopathologic analysis of 27 cases. Cancer 1984; 53: 2530–2545.
10.1002/1097-0142(19840601)53:11<2530::AID-CNCR2820531127>3.0.CO;2-J CAS PubMed Web of Science® Google Scholar
- 2 Kosari F, Daneshbod Y, Parwaresch R, et al. Lymphomas of the female genital tract: a study of 186 cases and review of the literature. Am J Surg Pathol 2005; 29: 1512–1520.
- 3 Signorelli M, Maneo A, Cammarota S, et al. Conservative management in primary genital lymphomas: the role of chemotherapy. Gynecol Oncol 2007; 104: 416–421.
- 4 Zhang H-Y, Lin T-Y, Jiang W-Q, et al. Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma. Chin J Cancer 2004; 23: 1681–1686.
- 5 Katsumata N, Matsuno Y, Nakayama H, et al. Prognostic factors and a predictive model of follicular lymphoma: a 25-year study at a single institution in Japan. Jpn J Clin Oncol 1996; 26: 445–454.
- 6 Fox H, More JR. Primary malignant lymphoma of the uterus. J Clin Pathol 1965; 18: 723–728.
- 7 Yamane T, Kirimoto K, Fujita M, et al. Ovarian involvement as an initial manifestation of malignant lymphoma. Jpn J Clin Oncol 1989; 19: 163–166.
- 8 Chan JK, Loizzi V, Magistris A, et al. Clinicopathologic features of six cases of primary cervical lymphoma. Am J Obstet Gynecol 2005; 193: 866–872.
- 9 Szantho A, Balega JJ, Csapo Z, Sreter LL, Matolcsy A, Papp Z. Primary non-Hodgkin's lymphoma of the uterine cervix successfully treated by neoadjuvant chemotherapy: case report. Gynecol Oncol 2003; 89: 171–174.
- 10 Miller TP, Jones SE. Chemotherapy of localised histiocytic lymphoma. Lancet 1979; 1: 358–360.
Citing Literature
